Filing Details

Accession Number:
0001209191-21-036229
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-27 16:10:32
Reporting Period:
2021-05-27
Accepted Time:
2021-05-27 16:10:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
949858 Achieve Life Sciences Inc. ACHV In Vitro & In Vivo Diagnostic Substances (2835) 954343413
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1477056 John Bencich 22722 29Th Dr Se
Suite 100
Bothell WA 98021
Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-05-27 6,000 $7.00 6,141 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The shares reported on this Form 4 were purchased in an underwritten public offering of the Issuer's common stock and are subject to a lock-up agreement between the reporting person and Oppenheimer & Co. Inc., pursuant to which the shares cannot be sold for 90 days following May 25, 2021.